Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Caron

Showing results (91-100 of 423) with videos related to

Pageof 43
Sort By:
Brain Communications|December 16, 2022
Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severityNicholas S Caron, Arsalan S Haqqani, Akshdeep Sandhu, et al.
BMC Biology|February 2, 2023
Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease modelsPaweł Joachimiak, Adam Ciesiołka, Emilia Kozłowska, et al.
Neurobiology of Disease|August 14, 2021
Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicityFanny L Lemarié, Nicholas S Caron, Shaun S Sanders, et al.
Obesity (Silver Spring, Md.)|March 21, 2013
A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese populationA Verrijken, S Beckers, S Francque, et al.
Frontiers in Aging Neuroscience|November 16, 2020
The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease NeuronsEmily Machiela, Ritika Jeloka, Nicholas S Caron, et al.
Molecular Therapy. Nucleic Acids|April 2, 2025
CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse modelsMagdalena Surdyka, Żaneta Kalinowska-Pośka, Anna Niewiadomska-Cimicka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European AncestryChris Kay, Jennifer A Collins, Niels H Skotte, et al.
Journal of Medical Genetics|December 1, 1998
Germline PTEN mutations in Cowden syndrome-like familiesD J Marsh, P L Dahia, S Caron, et al.
Scientific Reports|August 17, 2016
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington diseaseMarta Garcia-Miralles, Xin Hong, Liang Juin Tan, et al.
Scientific Reports|July 16, 2015
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppressionAmber L Southwell, Stephen E P Smith, Tessa R Davis, et al.
Pageof 43

Showing results (91-100 of 423) with videos related to

Sort By:
Pageof 43
Brain Communications|December 16, 2022
Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severityNicholas S Caron, Arsalan S Haqqani, Akshdeep Sandhu, et al.
BMC Biology|February 2, 2023
Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease modelsPaweł Joachimiak, Adam Ciesiołka, Emilia Kozłowska, et al.
Neurobiology of Disease|August 14, 2021
Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicityFanny L Lemarié, Nicholas S Caron, Shaun S Sanders, et al.
Obesity (Silver Spring, Md.)|March 21, 2013
A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese populationA Verrijken, S Beckers, S Francque, et al.
Frontiers in Aging Neuroscience|November 16, 2020
The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease NeuronsEmily Machiela, Ritika Jeloka, Nicholas S Caron, et al.
Molecular Therapy. Nucleic Acids|April 2, 2025
CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse modelsMagdalena Surdyka, Żaneta Kalinowska-Pośka, Anna Niewiadomska-Cimicka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European AncestryChris Kay, Jennifer A Collins, Niels H Skotte, et al.
Journal of Medical Genetics|December 1, 1998
Germline PTEN mutations in Cowden syndrome-like familiesD J Marsh, P L Dahia, S Caron, et al.
Scientific Reports|August 17, 2016
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington diseaseMarta Garcia-Miralles, Xin Hong, Liang Juin Tan, et al.
Scientific Reports|July 16, 2015
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppressionAmber L Southwell, Stephen E P Smith, Tessa R Davis, et al.
Pageof 43